Back to today’s briefing

Story perspectives

Study Links NRTIs to Reduced Alzheimer's Risk

5/8/2025

40 6

Summary

Story summary

A groundbreaking study from the University of Virginia reveals that NRTIs, commonly used for HIV and hepatitis B, could lower Alzheimer's risk by 4-13% for each year they are taken. This promising link stems from their potential to soothe brain inflammation, paving the way for innovative treatments that focus on inflammation rather than the typical protein buildups linked to Alzheimer's.

1 of 1

Story summary

A groundbreaking study from the University of Virginia reveals that NRTIs, commonly used for HIV and hepatitis B, could lower Alzheimer's risk by 4-13% for each year they are taken. This promising link stems from their potential to soothe brain inflammation, paving the way for innovative treatments that focus on inflammation rather than the typical protein buildups linked to Alzheimer's.